D05.92
Unspecified type of carcinoma in situ of left breast
Clinical Classification Guidelines
Medical Intelligence & Overview
Carcinoma in situ (CIS) of the breast is a non-invasive form of breast cancer where abnormal cells are confined within the ducts or lobules of the breast tissue. The term 'unspecified type' indicates that the precise classification of the carcinoma has not been determined. Specifically affecting the left breast, this condition requires careful medical assessment to determine its nature and appropriate management. While it is a pre-cancerous condition, without treatment, CIS can develop into invasive breast cancer. Early detection and diagnosis are crucial for effective treatment planning and improved outcomes.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting cell growth and division Hormonal factors, such as elevated estrogen levels Radiation exposure to the chest area Family history of breast cancer or carcinoma in situ Environmental influences and lifestyle factors like alcohol consumption and obesity
Key Symptoms: Often no symptoms are present, and the condition is found during routine screening or biopsy Possible presence of a small, painless lump or thickening in the breast tissue Nipple discharge or changes in nipple appearance Skin changes over the affected area, such as redness or puckering Breast discomfort or tenderness in some cases
Diagnostic & Treatment
Diagnosis Path: The diagnosis of carcinoma in situ of the left breast typically involves several key procedures:
Treatment Protocols: Management of carcinoma in situ of the breast varies depending on the extent and specific characteristics of the lesion. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is D05.92 a billable ICD-10 code?
Yes, D05.92 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D05.92?
Clinical documentation must specify the nature of Unspecified type of carcinoma in situ of left breast and any associated comorbidities for accurate reporting.
Cite this Clinical Reference